153 related articles for article (PubMed ID: 36438275)
21. Automated interpretation of PET/CT images in patients with lung cancer.
Gutte H; Jakobsson D; Olofsson F; Ohlsson M; Valind S; Loft A; Edenbrandt L; Kjaer A
Nucl Med Commun; 2007 Feb; 28(2):79-84. PubMed ID: 17198346
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?
Lee KH; Park CM; Lee SM; Lee JM; Cho JY; Paeng JC; Ahn SY; Goo JM
PLoS One; 2015; 10(6):e0129660. PubMed ID: 26065695
[TBL] [Abstract][Full Text] [Related]
23. A few-shot U-Net deep learning model for lung cancer lesion segmentation via PET/CT imaging.
Protonotarios NE; Katsamenis I; Sykiotis S; Dikaios N; Kastis GA; Chatziioannou SN; Metaxas M; Doulamis N; Doulamis A
Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 35144242
[TBL] [Abstract][Full Text] [Related]
24. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
25. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
26. Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT.
Kirienko M; Sollini M; Silvestri G; Mognetti S; Voulaz E; Antunovic L; Rossi A; Antiga L; Chiti A
Contrast Media Mol Imaging; 2018; 2018():1382309. PubMed ID: 30510492
[TBL] [Abstract][Full Text] [Related]
27. Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity.
Daouk J; Leloire M; Fin L; Bailly P; Morvan J; El Esper I; Saidi L; Moullart V; François G; Jounieaux V; Meyer ME
Acta Radiol; 2011 Jul; 52(6):651-7. PubMed ID: 21511870
[TBL] [Abstract][Full Text] [Related]
28. Supervised learning with cyclegan for low-dose FDG PET image denoising.
Zhou L; Schaefferkoetter JD; Tham IWK; Huang G; Yan J
Med Image Anal; 2020 Oct; 65():101770. PubMed ID: 32674043
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
30. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
[TBL] [Abstract][Full Text] [Related]
31. Is there a role for FDG PET in the management of lung cancer manifesting predominantly as ground-glass opacity?
Kim TJ; Park CM; Goo JM; Lee KW
AJR Am J Roentgenol; 2012 Jan; 198(1):83-8. PubMed ID: 22194482
[TBL] [Abstract][Full Text] [Related]
32. LUCIS: lung cancer imaging studies.
Harders SW
Dan Med J; 2012 Nov; 59(11):B4542. PubMed ID: 23171752
[TBL] [Abstract][Full Text] [Related]
33. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening.
Hadique S; Jain P; Hadi Y; Baig A; Parker JE
BMC Med Imaging; 2020 Jun; 20(1):69. PubMed ID: 32571221
[TBL] [Abstract][Full Text] [Related]
34. Towards large-scale case-finding: training and validation of residual networks for detection of chronic obstructive pulmonary disease using low-dose CT.
Tang LYW; Coxson HO; Lam S; Leipsic J; Tam RC; Sin DD
Lancet Digit Health; 2020 May; 2(5):e259-e267. PubMed ID: 33328058
[TBL] [Abstract][Full Text] [Related]
35. An assessment of
So A; Pointon O; Hodgson R; Burgess J
Clin Endocrinol (Oxf); 2018 May; 88(5):683-691. PubMed ID: 29446832
[TBL] [Abstract][Full Text] [Related]
36. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
37. Deep learning-based combination of [18F]-FDG PET and CT images for producing pulmonary perfusion image.
Gu J; Qiu Q; Zhu J; Cao Q; Hou Z; Li B; Shu H
Med Phys; 2023 Dec; 50(12):7779-7790. PubMed ID: 37387645
[TBL] [Abstract][Full Text] [Related]
38. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
39. Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions.
Salavati A; Borofsky S; Boon-Keng TK; Houshmand S; Khiewvan B; Saboury B; Codreanu I; Torigian DA; Zaidi H; Alavi A
Mol Imaging Biol; 2015 Feb; 17(1):140-8. PubMed ID: 25080325
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.
Chang MC; Chen JH; Liang JA; Lin CC; Yang KT; Cheng KY; Yeh JJ; Kao CH
Acad Radiol; 2012 Mar; 19(3):349-57. PubMed ID: 22173321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]